Efficacy and safety of proprotein convertase subtilisin/kexin 9 inhibitors in people with diabetes and dyslipidaemia - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Diabetes, Obesity and Metabolism Année : 2019

Efficacy and safety of proprotein convertase subtilisin/kexin 9 inhibitors in people with diabetes and dyslipidaemia

Bertrand Cariou
Fichier non déposé

Dates et versions

hal-03350259 , version 1 (21-09-2021)

Identifiants

Citer

Wieneke Dijk, Bertrand Cariou. Efficacy and safety of proprotein convertase subtilisin/kexin 9 inhibitors in people with diabetes and dyslipidaemia. Diabetes, Obesity and Metabolism, 2019, 21 (S1), pp.39-51. ⟨10.1111/dom.13636⟩. ⟨hal-03350259⟩
10 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More